ajmc.com, as data

#### Expanding Donor Access for ASCT in AML: Karilyn Larkin, MD#### Closing the Gap Between Myeloma Science and Access: Doris Hansen, MD## All News### Remote Monitoring and Self-Efficacy: Implications for Breast Cancer Survivorship OutcomesByIlana Graetz, PhD,Samuel Hernandez, BS,Xin Hu, PhD,Rebecca A. Krukowski, PhD,Gregory A.Vidal, MD, PhD,Lee Schwartzberg, MDRemote monitoring with tailored texts improved endocrine therapy adherence among breast cancer survivors with low symptom-management self-efficacy, with benefits becoming nonsignificant at higher self-efficacy levels.### FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 SuccessModerna’s mRNA flu vaccine receives FDA approval after phase 3 data showed improved efficacy compared with standard flu vaccines.### Predicting GLP-1 Discontinuation From Pharmacy ClaimsPublished: August 6th 2026 | Updated: August 31st 2026Health plans can use routine pharmacy claims to identify members at high risk for early discontinuation of glucagon-like peptide-1 receptor agonists and deliver targeted, equity-conscious adherence support.### CANN Responds to HRSA's Revised 340B Rebate Model PilotCANN says the revised pilot reflects stakeholder input and aims to address accountability challenges in the more than $100 billion 340B program.### Infection Remains a Major Burden in Blood CancersHigher CCI scores, prior infection, and prior prophylactic anti-infective treatment were associated with greater risk of subsequent infection in both cancers.### Lilly Expands Retatrutide Access Amid Doctor PushbackLilly opens early access to retatrutide for some patients before FDA approval, following scrutiny over a single earlier compassionate-use case.### Senate Confirms Erica Schwartz as CDC Director After Yearlong VacancyThe former deputy surgeon general takes over an agency that has lacked permanent leadership since Susan Monarez, PhD, was ousted.